Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

September 2014
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
SLAS Short Courses
01 Sep 2014 - 01 Sep 2014
Manchester, UK
SLAS Short Courses
More information
ELRIG - Drug Discovery 2014
02 Sep 2014 - 03 Sep 2014
Manchester, UK
ELRIG - Drug Discovery 2014
More information
Vaccine World Summit China 2014
04 Sep 2014 - 05 Sep 2014
Hangzhou, China
Vaccine World Summit China 2014
More information
15 Sep 2014 - 16 Sep 2014
Cambridge, MA, USA
Technology Transfer for Biologics
More information
15 Sep 2014 - 16 Sep 2014
Cambridge, MA, USA
Bioequivalence Summit
More information
4th China Vaccine Focus 2014
16 Sep 2014 - 17 Sep 2014
Shanghai, China
4th China Vaccine Focus 2014
More information
CNS Diseases World Summit 2014 
18 Sep 2014 - 19 Sep 2014
San Francisco, CA, USA
CNS Diseases World Summit 2014 
More information
7th CNS Partnering & Deal-Making 
18 Sep 2014 - 19 Sep 2014
San Francisco, CA, USA
7th CNS Partnering & Deal-Making 
More information
5th World Bispecific Antibody Summit
23 Sep 2014 - 25 Sep 2014
Boston, MA, USA
5th World Bispecific Antibody Summit
More information
<< 1 2 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!